204 related articles for article (PubMed ID: 23031370)
1. Metastatic atypical fibroxanthoma.
Satter EK
Dermatol Online J; 2012 Sep; 18(9):3. PubMed ID: 23031370
[TBL] [Abstract][Full Text] [Related]
2. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
3. Spindle Cell Atypical Fibroxanthoma: Myofibroblastic Differentiation Represents a Diagnostic Pitfall in This Variant of AFX.
Harding-Jackson N; Sangueza M; Mackinnon A; Suster S; Plaza JA
Am J Dermatopathol; 2015 Jul; 37(7):509-14; quiz 515-6. PubMed ID: 26098709
[TBL] [Abstract][Full Text] [Related]
4. Atypical fibroxanthoma presenting immunoreactivity against CD10 and CD99.
Nakamura Y; Abe Y; Ichimiya M; Muto M
J Dermatol; 2010 Apr; 37(4):387-9. PubMed ID: 20507414
[No Abstract] [Full Text] [Related]
5. Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma.
Soleymani T; Tyler Hollmig S
Curr Treat Options Oncol; 2017 Aug; 18(8):50. PubMed ID: 28762020
[TBL] [Abstract][Full Text] [Related]
6. Atypical Fibroxanthoma: A case series and review of literature.
Mahalingam S; Shah A; Stewart A
Auris Nasus Larynx; 2015 Dec; 42(6):469-71. PubMed ID: 25912604
[TBL] [Abstract][Full Text] [Related]
7. Atypical fibroxanthoma--a retrospective immunohistochemical study of 42 cases.
Singh M; Mann R; Ilankovan V; Hussein K; D'arrigo C
J Oral Maxillofac Surg; 2012 Nov; 70(11):2713-8. PubMed ID: 22494510
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
9. Oral undifferentiated high-grade pleomorphic sarcoma: report of a case.
Alfredo E; de Pádua JM; Vicentini EL; Marchesan MA; Comelli Lia RC; da Cruz Perez DE; Silva-Sousa YT
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e37-40. PubMed ID: 18155600
[TBL] [Abstract][Full Text] [Related]
10. Atypical Fibroxanthoma.
Chapman LW; Yu SS; Arron ST
Semin Cutan Med Surg; 2019 Mar; 38(1):E65-E66. PubMed ID: 31051027
[TBL] [Abstract][Full Text] [Related]
11. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
Soleymani T; Aasi SZ; Novoa R; Hollmig ST
Dermatol Clin; 2019 Jul; 37(3):253-259. PubMed ID: 31084719
[TBL] [Abstract][Full Text] [Related]
12. Atypical fibroxanthoma: a series of 25 cases.
Wollina U; Schönlebe J; Koch A; Haroske G
J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):943-6. PubMed ID: 20158588
[TBL] [Abstract][Full Text] [Related]
13. CD163 is not a sensitive marker for identification of atypical fibroxanthoma.
Beer TW
J Cutan Pathol; 2012 Jan; 39(1):29-32. PubMed ID: 22211334
[TBL] [Abstract][Full Text] [Related]
14. Atypical fibrous histiocytoma and atypical fibroxanthoma: presentation of two cases.
Kram A; Stańczyk J; Woyke S
Pol J Pathol; 2003; 54(4):267-71. PubMed ID: 14998296
[TBL] [Abstract][Full Text] [Related]
15. Atypical fibroxanthoma/malignant fibrous histiocytoma.
Marcet S
Dermatol Ther; 2008; 21(6):424-7. PubMed ID: 19076618
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum.
Chen SX; Eichenfield DZ; Orme C; Hinds B
Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045146
[TBL] [Abstract][Full Text] [Related]
17. Clear cell atypical fibroxanthoma:a clinicopathologic study.
Crowson AN; Carlson-Sweet K; Macinnis C; Taylor JR; Battaglia T; LaMar WL; Minor D; Sutter S; Hill T
J Cutan Pathol; 2002 Jul; 29(6):374-81. PubMed ID: 12135470
[TBL] [Abstract][Full Text] [Related]
18. Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma.
Miller K; Goodlad JR; Brenn T
Am J Surg Pathol; 2012 Sep; 36(9):1317-26. PubMed ID: 22510760
[TBL] [Abstract][Full Text] [Related]
19. The many faces of Atypical fibroxanthoma.
Agaimy A
Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
[TBL] [Abstract][Full Text] [Related]
20. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.
Ly H; Selva D; James CL; Huilgol SC
Australas J Dermatol; 2004 May; 45(2):106-9. PubMed ID: 15068457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]